control at the mean time. Patients , height, body weight, systolic blood pressure (SBP), diastolic blood pressure (DBP) were recorded. VOI¼1.33*SBP-0.33*DBP-133.3mmHg. Fasting blood glucose, blood lipid profile, liver and renal functions, routine blood test and fibrinogen were also determined. Flow mediated dilation (FMD) of brachial artery (BA) induced by reactive hyperemia was examined by high-resolution vascular ultrasound. The intima media thickness of bilateral carotid artery was also measured. CA-IMT was defined as 1.5mm with any presence of plaque on either side of the carotid artery. All patients underwent echocardiographic exam to detect LVMI. Results: Stepwise multiple regression analysis showed that VOI was an influencing factor for CA-IMT in all subjects. For an increase of 10mmHg of VOI, CA-IMT was thicken by 0.05mm, so as in EH patients. After stratification of age, sex and risk factors, VOI was found to be a persistent influencing factor for CA-IMT in hypertensives. Conclusions: VOI was an important influencing factor for CA-IMT in EH patients.
Objectives: Inter-regulation between components of the renin-angiotensin system (RAS) is common, but little is known about the direct regulatory roles of cardiac ACE2 and Mas expression. This study was to determine if the cardiac ACE2, ACE and Mas levels change in hypertensive rats treated with AT1 blocker, losartan and ACE inhibitor, enalapril. Methods: Forty rats were divided into 4 groups: sham operated (n¼10), rats with the aortic ligation (AL, n¼10), AL rats fed enalapril (20mg kg -1 d -1 , n¼10), and AL rats fed losartan (30mg kg -1 d -1 , n¼10). MAP was recorded using a tail-cuff method. After 4 week treatment, levels of ACE2, ACE and Mas receptor in the heart were examined by RT-PCR, western blot and immunohistochemistry. Results: Cardiac ACE mRNA and ACE protein levels were greater in AL rats than in controls (P<0.05). In AL rats with enalapril treatment, cardiac ACE mRNA and its protein levels were decreased (P<0.01). Cardiac ACE2 levels were lower in AL rats than in controls (P<0.01). Both enalapril and losartan increased the levels of cardiac ACE2 expression and decreased MAP, however, losartan seemed more efficient in control of MAP compared to enalapril. Interestingly, Mas mRNA rose in AL rats treated with losartan, but not with enalapril. Conclusions: Our findings demonstrate that enalapril and losartan increase the ratio of cardiac ACE2/ACE levels. Losartan significantly elevates the cardiac Mas expression but not enalapril. These results indicate that the protective effect of AT1 blockade on the heart may occur by increasing the activity of the cardiac ACE2-Ang (1-7) -Mas axis of the RAS.
GW25-e1075
The incidence of cough in hypertensive population treated with ACEI (Lisinopril) Objectives: To observe the incidence and start time of cough in hypertensive population treated with single Lisinopril. To investigate the relationship between cough and gender or age. Methods: Ninety-seven mild hypertensive patients were enrolled to receive single Lisinopril treatment after elution for three weeks. They were demanded follow-up visit every two weeks for 8 weeks after informed consent. The blood pressure (BP) was recorded as the average of 2 readings in each posture during each visit (standing posture following sitting posture). The mean value of BP and pulse in each posture and the start day of cough were recorded. All analyses were conducted using the SPSS package (version 13.0). Results: Fifty male and 47 female with the course of hypertension from 5 months to 26 years were enrolled. The average age was 48.40AE8.87 years. The BP after elution was (138.79AE14.29/94.42 AE6.88) mmHg (sitting posture) and (139.28AE15.50/98.11 AE8.38) mmHg (standing posture). The pulse was 72.25AE6.61/min (sitting posture) and 73.75AE6.72/min (standing posture). There were 42 patients (22 male and 19 female) happen to cough after admitted Lisinopril. The incidence of cough adverse effect was 44.00% in male and 42.55% in female. The start day of cough were: 14 cases (33.3%) in 5 day; 12 (28.6%) in 6-10 days, 7 (16.7%) in 11-20 days, 5 (11.9%) in 21-30 days, and 4 (9.5%) in 31-40 days. There was no significant difference in the percentage of cough presented by age, gender or the course of hypertension. Conclusions: The incidence of cough adverse effect was 44.0% in male and 42.55% in female with single Lisinopril treatment. Cough present was high in 10 days (61.9%). Cough adverse effect of Lisinopril was no significant difference in age, gender or the course of hypertension. Careful clinical observation is recommended when Lisinopril or other ACEI has to be prescribed.
GW25-e1665

Association between Plasma Homocysteine Levels and Blood Pressure Variability in Patients with Primary Hypertension
Gu Beiyin, Jiang Li Shanghai Tongren Hospital, ShangHai Jiao Tong University
Objectives: To investigate the association between homocysteine (Hcy) level and blood pressure variability (BPV) in patients with primary hypertension. Methods: A total of 154 patients diagnosed with primary hypertension (mean age: 56.48AE7.95 years; 103 males) were enrolled. All patients underwent blood sample tests and 24h ambulatory blood pressure (ABP) monitoring and were divided into two groups according to their Hcy levels: normal-Hcy group (n¼79) and high-Hcy group (n¼75). Indices including age, gender, smoking history, blood biochemical test data, and ABP, were statistically compared. Results: The percentage of male patients in the high-Hcy group (82.7%) was significantly greater than that in the normal-Hcy group (P<0.001). No office BP data differed significantly between the two groups. In the high-Hcy group, the night-time SBP variability (14.67AE5.74 mmHg) was significantly higher than in the normal-Hcy group (P¼0.034). In addition, the morning pressure surge in the high-Hcy group (20.62AE15.01 mmHg) was significantly higher than in the normal-Hcy group (P¼0.001). Further, multiple linear regression showed that the interaction between Hcy and the night-time SBP variability or the morning pressure surge was still significant after adjusting for the effect of age, gender, smoking and laboratory data. The night-time SDSBP and the morning pressure surge were both positively and significantly related to Hcy (P¼0.022 and P¼0.005, respectively). Conclusions: Plasma Hcy levels were associated with the variability in night-time SBP and the morning pressure surge in hypertensive patents. These findings suggest that increased night-time BPV and morning pressure surge may be a mediator for the link between hyperhomocysteinemia and target organ damage.
GW25-e2165
Left Ventricular Function Changes along with the Hypertension Progress in 2K-2C Rats
Liu Donghong, Liu Donghong, Liu Yanqiu, Li Cuilin, Yao Fengjuan, Lin Hong The 1st Affiliated Hospital of Sun Yat-sen University Objectives: Cardiac remodeling and myocardial dysfunction come with hypertension is well known. However it is not clear what is going on with hypertension developed. Our study is to evaluate the left ventricular function changes along with the hypertension progress in two kidney-two clip (2k-2c) rats. Methods: There were 18 rats assigned to a sham group and 2k-2c group (n¼9, each) for 12 weeks. Blood pressure, weight, cardiac morphological changed and left ventricular ejection fraction, and diastolic function indexes were recorded at 1w, 4w, 8w and 12w. Results: Along with hypertension progress, left ventricular mass indexes increased according with blood pressure elevated significantly (P<0.001, compared to sham group). But left ventricular ejection fraction has no obvious difference between the JACC Vol 64/16/Suppl C j October 16-19, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research C179
